Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07014111 · ClinicalTrials.gov registry record · NA

Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD

A NA study of End Stage Renal Disease on Dialysis, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07014111 is a NA study of End Stage Renal Disease on Dialysis that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 40 participants, below the 73-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07014111, a NA study of End Stage Renal Disease on Dialysis, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Fight Fatigue is evaluating the feasibility and acceptability of a combined progressive muscle relaxation and walking intervention to reduce fatigue for adults with end-stage kidney disease receiving in-center hemodialysis.

Conditions Studied

End Stage Renal Disease on Dialysis

Interventions

  • OTHER Attention Control
  • BEHAVIORAL Fight Fatigue

Study Locations (1)

Illinois

  • UI Health/University of Illinois Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-02
Est. Completion 2027-06
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07014111

The ClinicalTrials.gov registry entry for NCT07014111 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 73-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (45% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease on Dialysis appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.

NCT07014111 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07014111 about?

NCT07014111 is a clinical study titled "Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD". Fight Fatigue is evaluating the feasibility and acceptability of a combined progressive muscle relaxation and walking intervention to reduce fatigue for adults with end-stage kidney disease receiving in-center hemodialysis.

What is the current status of trial NCT07014111?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-02. Estimated completion is 2027-06.

What conditions does trial NCT07014111 study?

This clinical trial studies the following conditions: End Stage Renal Disease on Dialysis.

What interventions are being tested in trial NCT07014111?

The interventions under investigation include: Attention Control (OTHER), Fight Fatigue (BEHAVIORAL).

Who is sponsoring clinical trial NCT07014111?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07014111 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease on Dialysis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease on Dialysis

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.